Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX1CSX
|
||||
| Drug Name |
Acetic acid (2S,3S)-3-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-4-oxo-azetidin-2-yl ester
|
||||
| Synonyms |
CHEMBL417303
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H23N3O6
|
||||
| Canonical SMILES |
CC(=O)O[C@@H]1NC(=O)[C@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)OCc3ccccc3
|
||||
| InChI |
InChI=1S/C22H23N3O6/c1-14(26)31-21-18(20(28)25-21)24-19(27)17(12-15-8-4-2-5-9-15)23-22(29)30-13-16-10-6-3-7-11-16/h2-11,17-18,21H,12-13H2,1H3,(H,23,29)(H,24,27)(H,25,28)/t17-,18+,21-/m0/s1
|
||||
| InChIKey |
DTKJGQRHUHIVHR-UEXGIBASSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.